CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 58 filers reported holding CASTLE BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,926,457 | +102293.9% | 480,918 | +6.1% | 1.59% | -4.5% |
| Q4 2022 | $10,671 | -99.9% | 453,317 | +3.8% | 1.66% | -8.5% |
| Q3 2022 | $11,387,000 | +24.2% | 436,635 | +4.5% | 1.82% | +22.6% |
| Q2 2022 | $9,171,000 | +74.4% | 417,795 | +256.3% | 1.48% | +125.9% |
| Q1 2022 | $5,260,000 | +33.5% | 117,245 | +27.5% | 0.66% | +45.5% |
| Q4 2021 | $3,941,000 | -38.2% | 91,935 | -4.1% | 0.45% | -42.3% |
| Q3 2021 | $6,376,000 | -10.1% | 95,874 | -0.9% | 0.78% | -5.2% |
| Q2 2021 | $7,093,000 | +117.6% | 96,721 | +103.1% | 0.82% | +107.3% |
| Q1 2021 | $3,260,000 | +38.5% | 47,618 | +35.9% | 0.40% | +36.3% |
| Q4 2020 | $2,353,000 | +12.3% | 35,042 | -13.9% | 0.29% | -2.7% |
| Q3 2020 | $2,095,000 | +40.8% | 40,715 | +3.1% | 0.30% | +23.0% |
| Q2 2020 | $1,488,000 | -20.1% | 39,480 | -27.1% | 0.24% | +6.6% |
| Q4 2019 | $1,862,000 | +93.4% | 54,183 | +1.8% | 0.23% | +64.7% |
| Q3 2019 | $963,000 | – | 53,238 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |